platform deals

Lucid Diligence Brief - BioPharma

Bayer Completes Perfuse Therapeutics Acquisition for PER-001 | Lucid Diligence Brief

Bayer has closed its acquisition of Perfuse Therapeutics, securing full rights…

by Sreyashi Paul

Lucid Diligence Brief - Tech

Merck and Protillion Biosciences Collaboration Examined | Lucid Diligence Brief

Merck and Protillion partner on AI protein design. Assess milestones, platform…

by Sreyashi Paul

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: General Proximity and Daiichi Sankyo multi-target induced-proximity oncology deal

Lucid Diligence Brief: General Proximity and Daiichi Sankyo multi-target…

by Timos Papagatsias

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.